Extract from the Register of European Patents

About this file: EP1315496

EP1315496 - THE TREATMENT OF INFLAMMATORY DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.06.2006
Database last updated on 25.04.2019
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting statepublished on 14.10.2009  [2009/42]
Applicant(s)For all designated states
Arakis Ltd.
Chesterford Research Park, Little Chesterford Saffron Walden
Essex CB10 1XL / GB
Former [2005/33]For all designated states
Arakis Ltd.
Chesterford Research Park, Little Chesterford
Saffron Walden, Essex CB10 1KL / GB
Former [2005/09]For all designated states
Arakis Ltd.
Chesterford Research Park, Little Chesterford
Saffron Walden, Essex CB10 1XL / GB
Former [2003/23]For all designated states
Arakis Ltd.
Babraham Hall
Babraham Cambridge CB2 4AT / GB
Inventor(s)01 / SKEAD, Benjamin Mark, Celltech R & D Ltd.
Granta Park, Great Abington
Cambridge CB1 6GS / GB
02 / BANNISTER, Robin Mark, Arakis Ltd.
Babraham Hall, Babraham
Cambridge CB2 4AT / GB
03 / ROTHAUL, Alan, Arakis Ltd. Chesterford Res. Park
Little Chesterford Saffron Walden
Essex CB2 1XL / GB
Representative(s)Perry, Robert Edward
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
Former [2003/23]Perry, Robert Edward
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date01963202.531.08.2001
Priority number, dateGB2000002177605.09.2000         Original published format: GB 0021776
Filing languageEN
Procedural languageEN
PublicationType: A2  Application without search report
Type: A2 Application without search report 
The application has been published by WIPO in one of the EPO official languages on 14.03.2002
Type: B1 Patent specification 
Search report(s)International search report - published on:EP16.05.2002
ClassificationInternational:A61K31/49, A61P19/00, A61P17/06, A61P1/00, A61P11/08, A61P11/06
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/23]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
Entry into regional phase20.03.2003National basic fee paid 
20.03.2003Designation fee(s) paid 
20.03.2003Examination fee paid 
Examination procedure21.03.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.03.2003Examination requested  [2003/23]
08.09.2003Despatch of a communication from the examining division (Time limit: M06)
10.03.2004Reply to a communication from the examining division
29.12.2004Communication of intention to grant the patent
16.06.2005Fee for grant paid
16.06.2005Fee for publishing/printing paid
Opposition(s)18.05.2006No opposition filed within time limit [2006/30]
Fees paidRenewal fee
13.08.2003Renewal fee patent year 03
26.08.2004Renewal fee patent year 04
Lapses during opposition  TooltipTR17.08.2005
Cited inInternational search[XP]WO0066107  (APT PHARMACEUTICALS L L C [US]) [XP] 1-6 * abstract * * page 21, lines 15-18 * * page 44, lines 3-27; examples 1-3; claims 1,29,32-39 *;
 [X]WO9000055  (DAVIS MICHAEL H [US]) [X] 1,4 * abstract * * page 3, paragraph 3 - page 4, paragraph 4 *;
 [X]  - BATES, EDNA J. ET AL, "Stimulation of human neutrophil degranulation by mefloquine", INT. ARCH. ALLERGY APPL. IMMUNOL. (1988), 86(4), 446-52, XP000979855 [X] 1-6 * abstract * * page 446, column 1, paragraph 1 * * page 450, column 2, paragraphs 4,5 *
 [X]  - RAINSFORD K D, "EFFECTS OF ANTIMALARIAL DRUGS ON INTERLEUKIN 1-INDUCED CARTILAGE PROTEOGLYCAN DEGRADATION IN-VITRO", JOURNAL OF PHARMACY AND PHARMACOLOGY,GB,LONDON, (1986), vol. 38, no. 11, ISSN 0022-3573, pages 829 - 833, XP000889827 [X] 1,4 * abstract * * page 829, column 1, paragraph 1 *
 [X]  - FONTAGNE, J. ET AL, "Effects of some antimalarial drugs on rat inflammatory polymorphonuclear leukocyte function", BIOMED. PHARMACOTHER. (1989), 43(1), 43-51, XP000981559 [X] 1,4 * abstract * * page 44, column 1, paragraphs 1-3 * * page 50, column 2, paragraphs 2,3 *

DOI:   http://dx.doi.org/10.1016/0753-3322(89)90190-X
 [X]  - DEAN GOLDRING J P ET AL, "Antimalarial drugs modulate the expression of monocyte receptors.", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, (1999), vol. 21, no. 9, ISSN 0192-0561, pages 599 - 607, XP000979856 [X] 1,4 * abstract *

DOI:   http://dx.doi.org/10.1016/S0192-0561(99)00039-9